Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 82 of 588 for:    ESCITALOPRAM AND Celexa

Randomized, Double Blind, Efficacy Study of Escitalopram in ENT Cancer Patients Suffering From Emotional Distress (TADDOR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02246244
Recruitment Status : Completed
First Posted : September 22, 2014
Last Update Posted : June 10, 2016
Sponsor:
Information provided by (Responsible Party):
Gustave Roussy, Cancer Campus, Grand Paris

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 2013
Actual Study Completion Date : March 2013